Can Drugs Really Treat Sarcopenia? Some Patients Are Doubtful

Companies developing treatments for sarcopenia ‘have no idea what they're doing’, according to Ray Lipicky, a former director of the FDA’s Cardio-Renal Drug Products Division who spoke as a patient at the US agency’s sarcopenia drug development meeting.

Watch gears up close

More from Approval Standards

More from Pathways & Standards